title: COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression.
abstract: The COL11A1 human gene codes for the α1 chain of procollagen 11A1 and mature collagen 11A1, an extracellular minor fibrillar collagen. Under regular conditions, this gene and its derived products are mainly expressed by chondrocytes and mesenchymal stem cells as well as osteoblasts. Normal epithelial cells and quiescent fibroblasts from diverse locations do not express them. Mesenchyme-derived tumors and related conditions, such as scleroderma and keloids, are positive for COL11A1/(pro)collagen 11A1 expression, as well as high-grade human gliomas/glioblastomas. This expression is almost absent in benign pathological processes such as breast hyperplasia, sclerosing adenosis, idiopathic pulmonary fibrosis, cirrhosis, pancreatitis, diverticulitis, and inflammatory bowel disease. By contrast, COL11A1/(pro)collagen 11A1 is highly expressed by activated stromal cells of the desmoplastic reaction of different human invasive carcinomas, and this expression is correlated with carcinoma aggressiveness and progression, and lymph node metastasis. COL11A1 upregulation has been shown to be associated to TGF-β1, Wnt, and Hh signaling pathways, which are especially active in cancer-associated stromal cells. At the front of invasive carcinomas, neoplastic epithelial cells, putatively undergoing epithelial-to-mesenchymal transition, and carcinoma-derived cells with highly metastatic capabilities, can express COL11A1. Thus, in established metastases, the expression of COL11A1/(pro)collagen 11A1 could rely on both the metastatic epithelial cells and/or the accompanying activated stromal cells. COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human carcinoma-associated stromal cells and carcinoma progression.
authors.affiliation: Surgery Department, School of Medicine and Health Sciences, University of Oviedo, 33006, Oviedo, Spain.
authors.forename: Fernando
authors.initials: F
authors.lastname: Vázquez-Villa
authors.forename: Marcos
authors.initials: M
authors.lastname: García-Ocaña
authors.forename: José A
authors.initials: JA
authors.lastname: Galván
authors.forename: Jorge
authors.initials: J
authors.lastname: García-Martínez
authors.forename: Carmen
authors.initials: C
authors.lastname: García-Pravia
authors.forename: Primitiva
authors.initials: P
authors.lastname: Menéndez-Rodríguez
authors.forename: Carmen
authors.initials: C
authors.lastname: González-del Rey
authors.forename: Luis
authors.initials: L
authors.lastname: Barneo-Serra
authors.forename: Juan R
authors.initials: JR
authors.lastname: de Los Toyos
mesh_terms: D063646:Carcinogenesis; D002277:Carcinoma / Q000235:genetics* / Q000473:pathology; D024161:Collagen Type XI / Q000096:biosynthesis* / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009361:Neoplasm Invasiveness / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology; D053773:Transforming Growth Factor beta1 / Q000235:genetics
chemical_list: C574182:COL11A1 protein, human; D024161:Collagen Type XI; D053773:Transforming Growth Factor beta1